| Literature DB >> 25934356 |
Patrick Fénichel1, Françoise Brucker-Davis2, Nicolas Chevalier2.
Abstract
The Distilbène® story is a dramatic episode which belongs to the history of medicine. It provided several useful lessons such as the importance of evidence-based medicine and the hazard to develop treatments during pregnancy without careful animal verifications. However, this experience has also provided unexpected progress by suggesting new pathophysiological concepts: fetal programming of adult diseases and/or transgenerational transmission of environmental effects through epigenetic modifications.Entities:
Keywords: Adénocarcinome vaginal; Distilbène(®); Effet transgénérationnel; Endocrine disruptors; Exposition fœtale; Fetal exposure; Hypospadias; Perturbateurs endocriniens; Transgenerational effect; Vaginal adenocarcinoma
Mesh:
Substances:
Year: 2015 PMID: 25934356 DOI: 10.1016/j.ando.2015.03.008
Source DB: PubMed Journal: Ann Endocrinol (Paris) ISSN: 0003-4266 Impact factor: 2.478